These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 112739)

  • 1. Histocompatibility-dependent long-term islet of Langerhans survival induced by antithymocyte globulin.
    Beyer MM; Friedman EA
    Transplant Proc; 1979 Jun; 11(2):1436-9. PubMed ID: 112739
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of lymphokine-induced MHC antigen expression on islet allograft survival.
    Markmann JF; Bassiri HF; Barker CF; Naji A
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2723-4. PubMed ID: 2495681
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of antithymocyte globulin on islet of Langerhans transplantation.
    Friedman EA; Beyer MM
    Nephron; 1978; 22(1-3):212-6. PubMed ID: 106312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Islet of Langerhans allotransplantation in the rat.
    Nelken D; Friedman EA; Morse SI; Beyer MM
    Transplant Proc; 1977 Mar; 9(1):333-6. PubMed ID: 405774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of donor MHC compatibility in the allo- and autoimmune destruction of islet grafts in the BB rat.
    Stegall MD; Chabot JA; Tezuka K; Reemtsma K; Hardy MA
    Transplant Proc; 1990 Apr; 22(2):844. PubMed ID: 2109414
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of cryopreservation on islet allograft survival in diabetic rats.
    Höll E; Hering BJ; Bretzel RG; Federlin K
    Life Support Syst; 1985; 3 Suppl 1():675-9. PubMed ID: 3939684
    [No Abstract]   [Full Text] [Related]  

  • 7. Antithymocyte globulin (ATG) dosage and graft survival in renal transplantation.
    Kountz SL; Butt KH; Rao TK; Zielinski CM; Rafi M; Schultz JR
    Transplant Proc; 1977 Mar; 9(1):1023-5. PubMed ID: 325728
    [No Abstract]   [Full Text] [Related]  

  • 8. Postoperative bone marrow infusions with cyclosporine, silica, and antilymphocyte serum in rat islet allografts.
    Barneo L; Field MJ; Esteban MM
    Transplant Proc; 1990 Apr; 22(2):859-60. PubMed ID: 2158178
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of antithymocyte serum on cardiac allograft survival in thymectomized-splenectomized rats.
    Racelis D; Martinelli GP; Schanzer H
    Mt Sinai J Med; 1984 Jun; 51(3):262-7. PubMed ID: 6235450
    [No Abstract]   [Full Text] [Related]  

  • 10. Synergistic effect of donor-specific soluble membrane antigen injection and antithymocyte serum administration on the survival of islet allografts in rats.
    Vialettes B; Sutherland DE; Payne DE; Matas AJ; Najarian JS
    Transplantation; 1978 Jun; 25(6):336-8. PubMed ID: 78554
    [No Abstract]   [Full Text] [Related]  

  • 11. Extended survival of purified canine islet allografts with heterologous antilymphocyte globulin.
    Kaufman DB; Morel P; Field MJ; Roney M; Condie R; Sutherland DE
    Transplant Proc; 1991 Feb; 23(1 Pt 1):761-3. PubMed ID: 1990682
    [No Abstract]   [Full Text] [Related]  

  • 12. Substantial peripheral T-cell depletion before grafting is beneficial in islet transplantation.
    Brons IG; Davies HS; Watson CJ; Cobbold SP; Waldmann H; Calne RY
    Transplant Proc; 1995 Dec; 27(6):3181. PubMed ID: 8539899
    [No Abstract]   [Full Text] [Related]  

  • 13. Dissociation of skin and islet allograft rejection in antithymocyte globulin treated rats.
    Beyer MM; Lane FC; Friedman EA
    Transplant Proc; 1981 Mar; 13(1 Pt 2):815-8. PubMed ID: 6791336
    [No Abstract]   [Full Text] [Related]  

  • 14. Rabbit antithymocyte globulin induction and sirolimus monotherapy supports prolonged islet allograft function in a nonhuman primate islet transplantation model.
    Hirshberg B; Preston EH; Xu H; Tal MG; Neeman Z; Bunnell D; Soleimanpour S; Hale DA; Kirk AD; Harlan DM
    Transplantation; 2003 Jul; 76(1):55-60. PubMed ID: 12865786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of acute rejection of renal allografts with antithymocyte globulin or high-dosage prednisone. Influence of recipient DRw6 and DR matching.
    Hoitsma AJ; Van Lier HJ; Reekers P; Koene RA
    Neth J Med; 1985; 28(6):239-42. PubMed ID: 3892324
    [No Abstract]   [Full Text] [Related]  

  • 16. Superiority of soluble antigen extracts and antithymocyte globulin over whole blood and cytotoxic agents in inducing experimental allograft prolongation.
    Thomas F; Burke S; Thomas J; Lee HM; Lower RR
    Transplant Proc; 1979 Jun; 11(2):1442-3. PubMed ID: 382535
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of antilymphocyte serum on crude pancreatic islet allograft survival.
    Gotoh M; Maki T; Satomi S; Porter J; Monaco AP
    Transplant Proc; 1987 Feb; 19(1 Pt 1):576-7. PubMed ID: 3152704
    [No Abstract]   [Full Text] [Related]  

  • 18. Triple-combination therapy with cyclosporine, antithymocyte serum, and silica in pancreatic islet xenografting.
    Kanehiro H; Nakano H; Nakajima Y; Segawa M; Murao Y; Nakagawa K; Shiratori T
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1276-8. PubMed ID: 2856271
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies of privileged sites and islet transplantation.
    Barker CF; Markmann JF; Posselt AM; Naji A
    Transplant Proc; 1991 Aug; 23(4):2138-42. PubMed ID: 1871831
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of antipassenger lymphocyte globulin on functional graft survival of discordant xenoislet grafts from a large animal donor.
    Troppmann C; Papalois BE; Gruessner AC; Moon C; Matas AJ; Nakhleh RE; Gruessner RW
    Transplant Proc; 1996 Apr; 28(2):842-4. PubMed ID: 8623429
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.